Tuesday, September 27, 2016

Acido acexamico Austral




Acido acexamico Austral may be available in the countries listed below.


Ingredient matches for Acido acexamico Austral



Acexamic Acid

Acexamic Acid sodium salt (a derivative of Acexamic Acid) is reported as an ingredient of Acido acexamico Austral in the following countries:


  • Argentina

International Drug Name Search

Ethyl Chloride Spray


Pronunciation: ETH-il KLOR-ide
Generic Name: Ethyl Chloride
Brand Name: Gebauer's Ethyl Chloride


Ethyl Chloride Spray is used for:

Controlling pain associated with injections, minor surgical procedures, and certain other procedures. It is also used to temporarily relieve minor sports injuries. It may also be used for other conditions as determined by your doctor.


Ethyl Chloride Spray is a skin refrigerant. It works by freezing and numbing the skin.


Do NOT use Ethyl Chloride Spray if:


  • you are allergic to any ingredient in Ethyl Chloride Spray

Contact your doctor or health care provider right away if any of these apply to you.



Before using Ethyl Chloride Spray:


Some medical conditions may interact with Ethyl Chloride Spray. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have swollen, cut, or damaged skin at the application site

Some MEDICINES MAY INTERACT with Ethyl Chloride Spray. Because little, if any, of Ethyl Chloride Spray is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Ethyl Chloride Spray may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Ethyl Chloride Spray:


Use Ethyl Chloride Spray as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Do not apply to damaged, blistered, broken, or inflamed skin.

  • When using Ethyl Chloride Spray to freeze areas of skin, be sure to apply petrolatum to surrounding areas as directed by your doctor to avoid freezing outside the treatment site.

  • Be sure you understand how to properly use Ethyl Chloride Spray, including how far away from your skin you should hold the container and how long to spray it. Check with your doctor if you have any questions about the proper use of Ethyl Chloride Spray.

  • If you are using the amber bottle: Hold the bottle upside down while spraying. Be sure to open the spring valve completely to allow Ethyl Chloride Spray to flow from the bottle.

  • If you are using the aerosol can: Hold the can upright over the treatment area. Press the valve completely to allow Ethyl Chloride Spray to spray from the can.

  • If you miss a dose of Ethyl Chloride Spray, continue to use it as directed by your doctor.

Ask your health care provider any questions you may have about how to use Ethyl Chloride Spray.



Important safety information:


  • Ethyl Chloride Spray is for external use only. Do not get it in your eyes, nose, or mouth. If you get it in any of these areas, rinse immediately with cool water.

  • Do NOT use more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Do not inhale Ethyl Chloride Spray. Inhaling it may cause severe drowsiness and may lead to loss of consciousness, severe breathing problems, or coma. Discuss any questions or concerns with your doctor.

  • Do not apply Ethyl Chloride Spray over a large area without checking with your doctor.

  • Ethyl Chloride Spray is flammable. Do not store or use near an open flame, near certain electrical equipment, or while smoking.

  • It may be painful when your skin thaws after using Ethyl Chloride Spray. Discuss any questions or concerns with your doctor.

  • Freezing the skin may increase the risk of infection at the application site and may delay healing. Discuss any questions or concerns with your doctor.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Ethyl Chloride Spray while you are pregnant. If you are or will be breast-feeding while you use Ethyl Chloride Spray, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Ethyl Chloride Spray:


All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Temporary skin color changes.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); decreased urination; symptoms of liver problems (eg, dark urine; loss of appetite; pale stools; stomach pain; unusual nausea or tiredness; yellowing of the skin or eyes).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Ethyl Chloride side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Ethyl Chloride Spray:

Store Ethyl Chloride Spray at room temperature in a cool place. Store away from heat, moisture, and light. Do not store in the bathroom.


Contents are under pressure. Do not use or store near heat or open flame. Store away from direct sunlight. Do not expose the container to temperatures above 120 degrees F (50 degrees C). The container may burst. Do not puncture, break, or burn the canister even if it appears to be empty.


Keep Ethyl Chloride Spray out of the reach of children and away from pets.


General information:


  • If you have any questions about Ethyl Chloride Spray, please talk with your doctor, pharmacist, or other health care provider.

  • Ethyl Chloride Spray is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ethyl Chloride Spray. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ethyl Chloride resources


  • Ethyl Chloride Side Effects (in more detail)
  • Ethyl Chloride Use in Pregnancy & Breastfeeding
  • Ethyl Chloride Support Group
  • 0 Reviews · Be the first to review/rate this drug

Ascal




Ascal may be available in the countries listed below.


Ingredient matches for Ascal



Carbasalate Calcium

Carbasalate Calcium is reported as an ingredient of Ascal in the following countries:


  • Netherlands

International Drug Name Search

Anzoprol




Anzoprol may be available in the countries listed below.


Ingredient matches for Anzoprol



Lansoprazole

Lansoprazole is reported as an ingredient of Anzoprol in the following countries:


  • Brazil

International Drug Name Search

Abaglin




Abaglin may be available in the countries listed below.


Ingredient matches for Abaglin



Gabapentin

Gabapentin is reported as an ingredient of Abaglin in the following countries:


  • Argentina

International Drug Name Search

Paxil CR


See also: Generic Paxil


Paxil CR is a brand name of paroxetine, approved by the FDA in the following formulation(s):


PAXIL CR (paroxetine hydrochloride - tablet, extended release; oral)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: February 16, 1999

    Strength(s): EQ 12.5MG BASE [AB], EQ 25MG BASE [AB]


  • Manufacturer: GLAXOSMITHKLINE

    Approval date: December 6, 2000

    Strength(s): EQ 37.5MG BASE [RLD][AB]

Has a generic version of Paxil CR been approved?


A generic version of Paxil CR has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Paxil CR and have been approved by the FDA:


paroxetine hydrochloride tablet, extended release; oral



  • Manufacturer: MYLAN

    Approval date: June 29, 2007

    Strength(s): EQ 12.5MG BASE [AB], EQ 25MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: April 14, 2011

    Strength(s): EQ 37.5MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Paxil CR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Tablets with controlled-rate release of active substances
    Patent 5,422,123
    Issued: June 6, 1995
    Inventor(s): Conte; Ubaldo & La Manna; Aldo & Colombo; Paolo
    Assignee(s): Jagotec AG
    Tablets with zero order controlled-rate of release of the active substances, consisting of a core of defined geometrical form containing the active substance, polymer substances which swell on contact with aqueous liquids and polymer substances with gelling properties, and a support applied to said core to partly cover its surface, the support consisting of polymer substances which are slowly soluble and/or slowly gellable in aqueous liquids, plasticizing substances, and possibly substances with an adjuvant function.
    Patent expiration dates:

    • June 6, 2012


    • December 6, 2012
      ✓ 
      Pediatric exclusivity




  • Form of paroxetine hydrochloride anhydrate
    Patent 5,872,132
    Issued: February 16, 1999
    Inventor(s): Ward; Neal & Jacewicz; Victor Witold
    Assignee(s): SmithKline Beecham Corporation
    "Paroxetine hydrochloride (I) anhydrate ##STR1## free of bound propan-2-ol, and various forms thereof, are useful in the treatment of depression and other disorders for which administration of selective serotonin reuptake inhibitors are indicated."
    Patent expiration dates:

    • May 19, 2015


    • November 19, 2015
      ✓ 
      Pediatric exclusivity




  • Form of paroxetine hydrochloride anhydrate
    Patent 5,900,423
    Issued: May 4, 1999
    Inventor(s): Ward; Neal & Jacewicz; Victor Witold
    Assignee(s): SmithKline Beecham Corporation
    "Paroxetine hydrochloride (I) anhydrate ##STR1## free of bound propan-2-ol, and various forms thereof, are useful in the treatment of depression and other disorders for which administration of selective serotonin reuptake inhibitors are indicated."
    Patent expiration dates:

    • May 19, 2015


    • November 19, 2015
      ✓ 
      Pediatric exclusivity




  • Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder
    Patent 6,121,291
    Issued: September 19, 2000
    Inventor(s): Gleason; Maurice
    Assignee(s): SmithKline Beecham plc
    This invention relates to the use of paroxetine or a pharmaceutically acceptable salt thereof for the treatment of post-traumatic stress disorder and depression associated with withdrawal from heroin abuse.
    Patent expiration dates:

    • March 17, 2017
      ✓ 
      Patent use: DEPRESSION


    • September 17, 2017
      ✓ 
      Patent use: DEPRESSION
      ✓ 
      Pediatric exclusivity




  • Paroxetine hydrochloride form A or C
    Patent 6,133,289
    Issued: October 17, 2000
    Inventor(s): Ward; Neal & Jacewicz; Victor Witold
    Assignee(s): SmithKline Beecham Corporation
    Invented are methods of treatment using novel forms of paroxetine hydrochloride anhydrate.
    Patent expiration dates:

    • May 19, 2015
      ✓ 
      Patent use: DEPRESSION


    • November 19, 2015
      ✓ 
      Patent use: DEPRESSION
      ✓ 
      Pediatric exclusivity




  • Controlled release compositions
    Patent 6,548,084
    Issued: April 15, 2003
    Inventor(s): Graham Stanley; Leonard & David Philip; Elder
    Assignee(s): SmithKline Beecham plc
    A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxetine.
    Patent expiration dates:

    • July 19, 2016


    • January 19, 2017
      ✓ 
      Pediatric exclusivity




  • Paroxetine controlled release compositions
    Patent 7,229,640
    Issued: June 12, 2007
    Inventor(s): Leonard; Graham Stanley & Elder; David Philip
    Assignee(s): SmithKline Beecham p.l.c.
    A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.
    Patent expiration dates:

    • July 19, 2016
      ✓ 
      Patent use: DEPRESSION, PANIC DISORDER, PREMENSTRUAL DISORDERS AND SOCIAL ANXIETY DISORDER
      ✓ 
      Drug product



See also...

  • Paxil CR Controlled-Release Tablets Consumer Information (Wolters Kluwer)
  • Paxil CR Consumer Information (Cerner Multum)
  • Paxil CR Advanced Consumer Information (Micromedex)
  • Paroxetine Consumer Information (Drugs.com)
  • Paroxetine Consumer Information (Wolters Kluwer)
  • Paroxetine Controlled-Release Tablets Consumer Information (Wolters Kluwer)
  • Paroxetine Mesylate Consumer Information (Wolters Kluwer)
  • Paroxetine Suspension Consumer Information (Wolters Kluwer)
  • Paroxetine Consumer Information (Cerner Multum)
  • Paroxetine Advanced Consumer Information (Micromedex)
  • Paroxetine Hydrochloride AHFS DI Monographs (ASHP)

Anticoc Palumbus




Anticoc Palumbus may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Anticoc Palumbus



Pyrimethamine

Pyrimethamine is reported as an ingredient of Anticoc Palumbus in the following countries:


  • Portugal

Sulfaquinoxaline

Sulfaquinoxaline is reported as an ingredient of Anticoc Palumbus in the following countries:


  • Portugal

International Drug Name Search